DRREDDY
Active threads
Dr Reddy's faces Q1 earnings squeeze
Dr Reddy’s Laboratories (DRL) is expected to face considerable earnings pressure in the first quarter of the current fiscal ended June 30, 2026. The company will announce its first quarter numbers on July 22, 2026.
Dr. Reddy's stock dips below key moving average
Dr Reddys Share Price Live Updates: Dr. Reddy's Stock Dips Below Key Moving Average 27 Aug 2026 | 09:29:06 AM IST Dr Reddys share price live updates Welcome to the Dr Reddys Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent stocks in the market.
Dr Reddys launches stock live tracking blog
Dr Reddys Share Price Live Updates: Dr. Reddys Stock Details 25 Aug 2026 | 10:01:51 AM IST Dr Reddys share price live updates Welcome to the Dr Reddys Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ahead of the market with our in-depth coverage of Dr Reddys, including: Last traded price 1186.0, Market capitalization: 99017.59, Volume: 94743, Price-to-earnings ratio 30.76, Earnings per share 38.6.
Dr Reddy's Srikakulam Plant Gets FDA Observations
3 Min Read Hyderabad-based drug major Dr Reddy’s Laboratories Ltd on Wednesday (July 29) said the United States Food and Drug Administration (USFDA) has completed a Pre-Approval Inspection (PAI) and Good Manufacturing Practices (GMP) inspection at its FTO-SEZ Process Unit-02 in Srikakulam, Andhra Pradesh. The inspection was conducted from July 20, 2026, to July 29, 2026. Following the inspection, the company received a Form 483 containing three observations from the USFDA.
Dr Reddy's shares plummet sharply
Shares of Dr. Reddy’s continue to decline, breaching a key support level in the latest market action.
Intelligence feed
No articles in the last 24 hours.